Skip to content

Application of vasa Pratisarniya kshar in the management of abhyantara arsha ( internal haemorrhoids 1 st and 2nd degree

clinical study to evaluate the efficacy of vasa Pratisarniya kshar in the management of abhyantara arsha w.s.r internal haemorrhoid (1 st and 2nd degree) - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089106
Enrollment
45
Registered
2025-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K649- Unspecified hemorrhoids

Interventions

None listed

Sponsors

Dr Alok Kumar yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Arsha who are fulfilling my study criteria and who are willing to be selected will be enrolled Patients with 1st and 2nd degree haemorrhoids Patient of the age group above 30 years below 60 years Patient will be selected irrespective of sex Patients who will be ready to give written consent

Exclusion criteria

Exclusion criteria: Patients planning to conceive in near future[during course of trial] Any congenital diseases like haemophillia Patients with 3 degree, 4 degree or prolapsed piles Pregnant women and Lactating mothers Patients suffering from Thrombosed Piles mass,Ulcerative Colitis and CA rectum

Design outcomes

Primary

MeasureTime frame
Reduction in size of pile massTimepoint: 21 days or 3 week The trial drug will be given for 3 weeks and follow up will be done after 3rd week

Secondary

MeasureTime frame
Bleeding reduced per rectum and relief in burning sensationTimepoint: After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement. Partially improvement after 7 days patient gets 30 percent relief from sign and symptoms Improvement after 14 days patient gets 50-60 percent relief from sign and symptoms Cured after 21 days patient gets 80-100 percent relief from sign and symptoms.

Countries

India

Contacts

Public ContactDr Elizabeth P John

Vaidya yagya dutt sharma Ayurved Mahavidyalaya Khurja Bulandshahr

elizajhn@yahoo.co.in9877938128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026